Sun Pharmaceutical Industries Limited
SUNPHARMA · NSE · Pharmaceuticals
About the company
Sun Pharma is India's largest pharmaceutical company by market capitalisation and the fourth-largest specialty generic pharmaceutical company globally. It manufactures and markets a broad range of branded and generic formulations across over 100 countries. Key focus areas include dermatology, oncology, ophthalmology, and specialty medicines.
| Exchange | NSE |
| Ticker | SUNPHARMA |
| Sector | Pharmaceuticals |
| Indicative market cap USD | $44.00B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (NSE), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- National Stock Exchange of India — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in India
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.